|
gptkbp:instance_of
|
gptkb:vaccine
|
|
gptkbp:accessories
|
gptkb:UNICEF
private healthcare providers
public health systems
|
|
gptkbp:accreditation
|
gptkb:ISO_9001
|
|
gptkbp:awards
|
various industry awards
|
|
gptkbp:certification
|
WHO prequalification
|
|
gptkbp:clinical_research
|
vaccine efficacy studies
|
|
gptkbp:clinical_trial
|
conducts vaccine trials
|
|
gptkbp:collaboration
|
gptkb:GAVI_Alliance
|
|
gptkbp:collaborations
|
various universities
|
|
gptkbp:community_engagement
|
health awareness programs
|
|
gptkbp:community_health
|
immunization programs
|
|
gptkbp:covid-19_response
|
produced vaccines
|
|
gptkbp:employees
|
over 5000
|
|
gptkbp:focus_area
|
infectious diseases
|
|
gptkbp:founded
|
gptkb:1966
|
|
gptkbp:founder
|
gptkb:Cyrus_Poonawalla
|
|
gptkbp:global_distribution
|
over 170 countries
|
|
gptkbp:global_health
|
contributes to global vaccination efforts
|
|
gptkbp:global_partnerships
|
health organizations
|
|
gptkbp:head
|
gptkb:Adar_Poonawalla
|
|
gptkbp:headquarters
|
gptkb:Pune,_India
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Serum Institute of India
|
|
gptkbp:innovation
|
vaccine development technologies
|
|
gptkbp:investment
|
$800 million in expansion
|
|
gptkbp:manufacturer
|
gptkb:MMR_vaccine
gptkb:HPV_vaccine
gptkb:hepatitis_B_vaccine
gptkb:rabies_vaccine
BCG vaccine
polio vaccine
COVID-19 vaccines
diphtheria vaccine
tetanus vaccine
meningococcal vaccine
|
|
gptkbp:notable_products
|
gptkb:Covishield
|
|
gptkbp:part_of
|
gptkb:Poonawalla_Group
|
|
gptkbp:partnership
|
gptkb:Astra_Zeneca
|
|
gptkbp:partnerships
|
government agencies
|
|
gptkbp:production_volume
|
1.5 billion doses per year
|
|
gptkbp:products
|
vaccines
|
|
gptkbp:public_health_impact
|
gptkb:significant
|
|
gptkbp:regulatory_compliance
|
multiple countries
|
|
gptkbp:research_and_development
|
vaccine technology
|
|
gptkbp:research_interest
|
significant funding
|
|
gptkbp:revenue
|
over $1 billion
|
|
gptkbp:social_responsibility
|
affordable vaccines
|
|
gptkbp:supply_chain
|
global logistics
|
|
gptkbp:sustainability_initiatives
|
green manufacturing
|
|
gptkbp:vaccine_accessibility
|
improving access
|
|
gptkbp:vaccine_distribution
|
international organizations
|
|
gptkbp:vaccine_distribution_network
|
extensive
|
|
gptkbp:vaccine_effectiveness
|
high efficacy rates
|
|
gptkbp:vaccine_innovation
|
new formulations
|
|
gptkbp:vaccine_research
|
ongoing projects
|
|
gptkbp:vaccine_safety
|
stringent testing
|
|
gptkbp:vaccine_storage
|
cold chain logistics
|
|
gptkbp:bfsParent
|
gptkb:Covishield
|
|
gptkbp:bfsLayer
|
5
|